Art

J-GLOBAL ID：201802222220954206   Reference number：18A2058037

Effects of Magnesium Oxide on the Serum Duloxetine Concentration and Antidepressant-Like Effects of Duloxetine in Rats

ラットにおける血清デュロキセチン濃度およびデュロキセチンの抗うつ薬様作用に及ぼす酸化マグネシウムの影響

Author (10)： Esumi Satoru (Department of Hospital Pharmacy, Okayama University Medical School) ,  Kitamura Yoshihisa (Department of Hospital Pharmacy, Okayama University Medical School) ,  Yokota-Kumasaki Hitomi (Department of Hospital Pharmacy, Okayama University Medical School) ,  Yokota-Kumasaki Hitomi (Department of Pharmacy, Osaka General Medical Center) ,  Ushio Soichiro (Department of Hospital Pharmacy, Okayama University Medical School) ,  Yamada-Takemoto Akane (Department of Hospital Pharmacy, Okayama University Medical School) ,  Nagai Ryo (Department of Hospital Pharmacy, Okayama University Medical School) ,  Ogawa Atsushi (Department of Hospital Pharmacy, Okayama University Medical School) ,  Kawasaki Yoichi (Department of Hospital Pharmacy, Okayama University Medical School) ,  Sendo Toshiaki (Department of Hospital Pharmacy, Okayama University Medical School)
Material： Biological and Pharmaceutical Bulletin (Web)
Volume： 41  Issue： 11  Page： 1727-1731(J-STAGE)  Publication year： 2018 
JST Material Number： U1402A  ISSN： 1347-5215  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Rattus ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A2058037&from=J-GLOBAL&jstjournalNo=U1402A") }}

Author keywords (8)： duloxetine ,  magnesium oxide ,  forced swimming test ,  HPLC ,  duloxetine ,  magnesium oxide ,  forced swimming test ,  HPLC

JST classification (3)： Interactions of drugs  (GV01070X) ,  Basic research of psychotropic drugs  (GW03100Y) ,  Basic research of drugs acting on digestive system  (GW09010Q)

Substance index (1)： Duloxetine

Reference (19)：

• 1) Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur. Psychiatry, 21, 367-378 (2006).
• 2) Bailey RK, Mallinckrodt CH, Wohlreich MM, Watkin JG, Plewes JM. Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy. J. Natl. Med. Assoc., 98, 437-447 (2006).
• 3) Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y, Japanese Study Group for the Relief of Opioid-induced Gastrointestinal Dysfunction. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin. J. Pain, 28, 373-381 (2012).
• 4) Yamasaki M, Funakoshi S, Matsuda S, Imazu T, Takeda Y, Murakami T, Maeda Y. Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy. Eur. J. Clin. Pharmacol., 70, 921-924 (2014).
• 5) McBain J, Dunn RC. Sorption from solution by active magnesium oxide. J. Colloid Sci., 3, 303-311 (1948).

Terms in the title (5)： ラット ,  血清 ,  デュロキセチン ,  抗うつ薬 ,  酸化マグネシウム